CORONARY INTERVENTIONS

A novel constrained, paclitaxel-coated angioplasty balloon catheter

EuroIntervention 2017;12:2140-2147 published online November 2016. DOI: 10.4244/EIJ-D-16-00093

Bodo Cremers
Bodo Cremers1, MD; Gary Binyamin2, PhD; Yvonne P. Clever1, MD; Paul Seifert2, PhD; Eitan Konstantino2, PhD; Bettina Kelsch3, PhD; Stephanie Bienek4, PhD; Ulrich Speck3, PhD; Bruno Scheller1*, MD
1. Universitaetsklinikum des Saarlandes, Homburg/Saar, Germany; 2. TriReme Medical, LLC, Pleasanton, CA, USA; 3. Department of Radiology, Charité, Humboldt University Berlin, Berlin, Germany; 4. InnoRa GmbH, Berlin, Germany

Aims: The study aimed to assess drug adherence, transfer to the vessel wall, tolerance and efficacy of a constrained angioplasty balloon coated with an excipient-enhanced paclitaxel coati

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

drug-coated balloonsrevascularisationstent overstretch model
Coronary interventionsPeripheral interventionsOther coronary interventionsOther peripheral interventionsOther
Read next article
Ultra-hydrophilic stent platforms promote early vascular healing and minimise late tissue response: a potential alternative to second-generation drug-eluting stents

Latest news